FDA rejects Rexulti's approval for PTSD treatment, citing insufficient evidence of effectiveness in combination with sertraline. Otsuka and Lundbeck announced they are planning next steps.
Robert Gamble, CEO of RxBenefits, shares how Illuminate Rx does specialty, plus the areas they will continue to innovate on.
The FDA letter requested that a technical information update be included in the Chemistry Manufacturing and Controls (CMC) ...
Research shows older adults had 4.45 million skin cancer cases in 2021. Basal cell carcinoma is expected to double by 2050 worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback